Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02872220 · ClinicalTrials.gov registry record · NA
To Test for Photo Allergy Reaction of Sunscreens
A NA study, sponsored by Bayer.
- Completed
- Registry status
- NA
- Development phase
- 56
- Enrollment target
NCT02872220 is a NA study that has completed, run by Bayer. The registered enrollment target is 56 participants.
The verdict
NCT02872220, a NA study, has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- NA
- Development phase
- 56 participants
- Enrollment target
Study Summary
The primary objective of this tudy was to evaluate the potential of photoallergy of of sun care products Sun Protection Factor (SPF) 50 Y65 110, SPF 50 Y51 002, and SPF 15 V27 104 application compared to that of a negative control (0.9% sodium chloride, NaCl) and followed by irradiation with UV A and UVB. The secondary objective aims for evaluation of the safety of SPF 50 Y65 110, SPF 50 Y51 002, and SPF 15 V27 104 combined with ultraviolet (UV) A/B irradiation by monitoring adverse events (AEs) throughout the study.
Interventions
- DRUG SPF 50 Y65 110 (BAY987519)
- DRUG SPF 50 Y51 002 (BAY987519)
- DRUG SPF 15 V27 104 (BAY987519)
- DRUG Sodium chloride [NaCl]
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2015-03-23 |
| Est. Completion | 2015-05-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02872220
The ClinicalTrials.gov registry entry for NCT02872220 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 56 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bayer, which has 591 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which SPF 50 Y65 110 (BAY987519) is the first listed.
NCT02872220 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02872220 about?
NCT02872220 is a clinical study titled "To Test for Photo Allergy Reaction of Sunscreens". The primary objective of this tudy was to evaluate the potential of photoallergy of of sun care products Sun Protection Factor (SPF) 50 Y65 110, SPF 50 Y51 002, and SPF 15 V27 104 application compared to that of a negative control (0.9% sodium chloride, NaCl) and followed by irradiation with UV A an...
What is the current status of trial NCT02872220?
This trial is currently completed. It is a NA study. The enrollment target is 56 participants. The study started on 2015-03-23. Estimated completion is 2015-05-08.
What interventions are being tested in trial NCT02872220?
The interventions under investigation include: SPF 50 Y65 110 (BAY987519) (DRUG), SPF 50 Y51 002 (BAY987519) (DRUG), SPF 15 V27 104 (BAY987519) (DRUG), Sodium chloride [NaCl] (DRUG).
Who is sponsoring clinical trial NCT02872220?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.